AzTrials
AzTrials

Bone HealingNCT06766292

Osteogenic Potential of Schneiderian Membrane

A study testing primary intervention and open sinus lifting with xenograft only in people with Bone Healing and Sinus Membrane Osteoginicity, run by rehab soliman at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Maxillary sinus augmentation is commonly performed by creating a space below the Schneiderian membrane which is further filled using autografts, bone graft substitutes, or a combination of both to allow for new bone formation. Read more about this study

Who is it for?
Ages 25 to 55 yearsHealthy volunteers can take part
Conditions the study is for
Bone Healing, Sinus Membrane Osteoginicity
What is being tested?
primary intervention and open sinus lifting with xenograft only
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
14 participants
Where
1 siteEgypt
Study dates
27 Aug 2023to 3 Sep 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 25 to 55 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Adult male/female patients above the age of 25.
  • Patients with one or more teeth requiring implant supported dental restoration in atrophic maxilla (unilateral or bilateral).
  • Alveolar bone height less than 4 mm at the defective site.
  • Good oral hygiene.

Who cannot join

  • Medically compromised patients with conditions contraindicating surgery (eg. uncontrolled diabetics, bisphosphonate intake, radio or chemotherapy).
  • Patients with active infection at or related to the site of surgery (eg. acute sinusitis).
  • Heavy smokers.
  • Patients not indicated for an implant supported restoration at the time of enrollment (eg. active/untreated periodontal disease).

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Suez Canal University

    Ismailia, 41522

Other trials in Egypt

About this study

Official title: Clinical, Radiographic and Histologic Assessment of the Osteogenic Potential of Schneiderian Membrane After Maxillary Sinus Lifting: A Randomized Controlled Clinical Trial.

Maxillary sinus augmentation is commonly performed by creating a space below the Schneiderian membrane which is further filled using autografts, bone graft substitutes, or a combination of both to allow for new bone formation. Recently, a new method called non-grafting sinus floor augmentation has been introduced as an alternative approach. This method is based on the idea of elevating the membrane and supporting it through implant insertion or the use of space-maintaining devices like titanium screws or mesh. This study was conducted to evaluate the efficacy of new bone formation after sinus floor elevation using space maintaining resorbable pins without graft material.

Read the detailed description

A randomized control trial was performed on 14 patients with partially edentulous or free end saddle posterior maxilla. The patients were divided randomly into two groups. Both groups underwent maxillary sinus open lifting procedure and augmentation using xenograft * as group A and in group B the sinus membrane was elevated and stabilized by resorbable pins** to maintain the created space stable and without grafting. The study was a double blind one (participants and out¬come assessors were blinded throughout the study).

All the surgical procedures were carried out un¬der local anesthesia using infraorbital and posterior superior alveolar nerve block with palatal infiltration. Full thickness mucoperiosteal flap was elevated to expose the lateral wall of the maxillary sinus. Then the maxil¬lary sinus floor elevation using the lateral window technique was performed. A bone window was outlined using a no. 8 diamond bur mounted on straight hand piece with copious irrigation (sterile saline solution) with cautious taken to not penetrate the sinus membrane. The process of bone removal was done through the cortical bone to reach the membrane without perforation. Complete osteotomy along the boundary of the osseous window until the Schneiderian mem-brane. The Schneiderian membrane was carefully elevated till the desired height.

xenograft Preparation: (control group/ group A)

Xenograft was mixed with saline followed by the protocol of graft packed and compacted against inferior walls and to the sides of the antrum until the new available volume created was filled. The lateral window was covered by collagen membrane before flap closure. Resorbable pins (test group/ group B):

In the study group: 2.0 mm screws were fixed to the lateral wall of the sinus above the superior osteotomy and placed buccopalatally where the schneiderian membrane was elevated and maintained. Then the soft tissue flap was readapted and sutured using continuous and interrupted sutures (3-0 resorbable vicryl)

Being tested
primary intervention, open sinus lifting with xenograft only
Keywords
sinus lifting, maxillary sinus augmentation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • primary interventionProcedure or surgery

    In the study group: 2.0 mm screws were fixed to the lateral wall of the sinus above the superior osteotomy and placed buccopalatally where the schneiderian membrane was elevated and maintained. this technique will suspends the membrane in position to allow the blood clot to organized and formation of bone.

  • open sinus lifting with xenograft onlyProcedure or surgery

    ll Patients in this group underwent open sinus procedures to lift the sinus membrane followed by application of the xenograft as an augmentation material xenograft is used instead of autogenous bone graft to avoid the morbidity of the donor side

Study groups in NCT06766292
Study groupRoleWhat they receive
Control GroupActive comparatorin this group, the patients underwent open sinus lifting surgery and augmentation of the sinuses by xenograft without any additives
Receives: Procedure: open sinus lifting with xenograft only
study groupExperimentalIn the study group: 2.0 mm screws were fixed to the lateral wall of the sinus above the superior osteotomy and placed buccopalatally where the schneiderian membrane was elevated and maintained.
Receives: Procedure: primary intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. bone height

    will be measured using CBCT (Cone Beam Computed Tomography)

    Measured: 8 months

Secondary outcomes (1)
  1. histological analysis

    will be measured using hematoxylin and eosin stains

    Measured: 8 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Jan 2025
  2. Study start27 Aug 2023
  3. Primary completion3 Aug 2024
  4. Study completion3 Sep 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Participant, Investigator, Outcomes assessor
Enrolment
14 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06766292
Sponsor's protocol ID
672/2023
Status last verified
Aug 2025
First submitted
5 Jan 2025
Last updated
11 Aug 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • ElSholkamy M, Mokhtar RH, Eltayeb TM, Helwa I, Soliman RA. Clinical, radiographic and histomorphometry evaluation of the osteogenic potential of Schneiderian membrane after graftless maxillary sinus augmentation: a randomized controlled clinical trial. BMC Oral Health. 2026 Feb 19;26(1):417. doi: 10.1186/s12903-026-07772-2.

    PubMed 41715114

Questions about this trial

What is this clinical trial studying?

A study testing primary intervention and open sinus lifting with xenograft only in people with Bone Healing and Sinus Membrane Osteoginicity, run by rehab soliman at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 11 Aug 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

bone height (time frame: 8 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06766292, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Aug 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in